Vital Therapies (VTL) Tops Q3 EPS by 2c

Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.30), $0.02 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• BofA says investors are increasingly worried about an AI boom-bust cycle
• Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance